Document is current
Any future updates will be listed below
-
Authors
Kim, Kyunghee
Kim, Hyeonjoong
Kim, Hyeyun
Shin, Jung-Won
Sunwoo, Jun-Sang
Byun, Jung-Ick
Hwang, Kyoung Jin
Ha, Jiyeon
Lee, Mangyeong
Cho, Juhee
Park, Jonghwa Jeonglok
Jung, Ki-Young
- License Information
-
More Information
Article History
Received: 30 December 2025
Accepted: 26 June 2026
First Online: 9 July 2026
Declarations
:
: This study was approved by the Institutional Review Board of Kyung Hee University Hospital at Gangdong (KHNMC IRB 2025-11-028; approved November 25, 2025) and by the IRBs of all participating sites.
: Not applicable.
: KK and JH are employees of Bell Therapeutics Inc., the sponsor and developer of BELL-001. JJP is the chief executive officer of Bell Therapeutics Inc. HK and KYJ are shareholders of Bell Therapeutics Inc. All other authors declare no competing interests.
